Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Breast Neoplasms and ARID1A[original query] |
---|
Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. Proceedings of the National Academy of Sciences of the United States of America 2015 Jan 112 (4): 1107-12. Chen Kexin, Yang Da, Li Xiangchun, Sun Baocun, Song Fengju, Cao Wenfeng, Brat Daniel J, Gao Zhibo, Li Haixin, Liang Han, Zhao Yanrui, Zheng Hong, Li Miao, Buckner Jan, Patterson Scott D, Ye Xiang, Reinhard Christoph, Bhathena Anahita, Joshi Deepa, Mischel Paul S, Croce Carlo M, Wang Yi Michael, Raghavakaimal Sreekumar, Li Hui, Lu Xin, Pan Yang, Chang Han, Ba Sujuan, Luo Longhai, Cavenee Webster K, Zhang Wei, Hao Xish |
MEGSA: A Powerful and Flexible Framework for Analyzing Mutual Exclusivity of Tumor Mutations. American journal of human genetics 2016 Feb . Hua Xing, Hyland Paula L, Huang Jing, Song Lei, Zhu Bin, Caporaso Neil E, Landi Maria Teresa, Chatterjee Nilanjan, Shi Jianx |
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers. Breast cancer research and treatment 2017 Nov 166 (1): 179-184. Santa-Maria Cesar A, Kruse Megan, Raska Paola, Weiss Mia, Swoboda April, Mutonga Martin B, Abraham Jame, Jain Sarika, Nanda Rita, Montero Alberto |
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer. Breast cancer research : BCR 2018 Aug 20 (1): 88. Liang Xu, Vacher Sophie, Boulai Anais, Bernard Virginie, Baulande Sylvain, Bohec Mylene, Bièche Ivan, Lerebours Florence, Callens Céli |
Phosphatidylinositol 3-Kinase ?-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 2 36 (13): 1291-1299. Juric Dejan, Rodon Jordi, Tabernero Josep, Janku Filip, Burris Howard A, Schellens Jan H M, Middleton Mark R, Berlin Jordan, Schuler Martin, Gil-Martin Marta, Rugo Hope S, Seggewiss-Bernhardt Ruth, Huang Alan, Bootle Douglas, Demanse David, Blumenstein Lars, Coughlin Christina, Quadt Cornelia, Baselga Jo |
Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient. Breast cancer research and treatment 2018 Jul 170 (1): 179-188. Johnson Julie, Bessette Darrell C, Saunus Jodi M, Smart Chanel E, Song Sarah, Johnston Rebecca L, Cocciardi Sibylle, Rozali Esdy N, Johnstone Cameron N, Vargas Ana Christina, Kazakoff Stephen H, BioBank Victorian Cancer, Khanna Kum Kum, Lakhani Sunil R, Chenevix-Trench Georgia, Simpson Peter T, Nones Katia, Waddell Nicola, Al-Ejeh Far |
Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 9 26 (23): 6254-6265. Richard François, Majjaj Samira, Venet David, Rothé Françoise, Pingitore Julien, Boeckx Bram, Marchio Caterina, Clatot Florian, Bertucci François, Mariani Odette, Galant Christine, Eynden Gert van den, Salgado Roberto, Biganzoli Elia, Lambrechts Diether, Vincent-Salomon Anne, Pruneri Giancarlo, Larsimont Denis, Sotiriou Christos, Desmedt Christi |
Differences in Genomic Alterations Between Brain Metastases and Primary Tumors. Neurosurgery 2020 Dec . Dono Antonio, Takayasu Takeshi, Yan Yuanqing, Bundrant Bethany E, Arevalo Octavio, Lopez-Garcia Carlos A, Esquenazi Yoshua, Ballester Leomar |
Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort. Scientific reports 2020 11 10 (1): 19304. Mathioudaki Argyri, Ljungström Viktor, Melin Malin, Arendt Maja Louise, Nordin Jessika, Karlsson Åsa, Murén Eva, Saksena Pushpa, Meadows Jennifer R S, Marinescu Voichita D, Sjöblom Tobias, Lindblad-Toh Kerst |
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative. Cancer discovery 2021 6 11 (11): 2796-2811. Aftimos Philippe, Oliveira Mafalda, Irrthum Alexandre, Fumagalli Debora, Sotiriou Christos, Gal-Yam Einav Nili, Robson Mark E, Ndozeng Justin, Di Leo Angelo, Ciruelos Eva M, de Azambuja Evandro, Viale Giuseppe, Scheepers Elsemieke D, Curigliano Giuseppe, Bliss Judith M, Reis-Filho Jorge S, Colleoni Marco, Balic Marija, Cardoso Fatima, Albanell Joan, Duhem Caroline, Marreaud Sandrine, Romagnoli Dario, Rojas Beatriz, Gombos Andrea, Wildiers Hans, Guerrero-Zotano Angel, Hall Peter, Bonetti Andrea, Larsson Karolina Fs, Degiorgis Martina, Khodaverdi Silvia, Greil Richard, Sverrisdóttir Ásgerdur, Paoli Marta, Seyll Ethel, Loibl Sibylle, Linderholm Barbro, Zoppoli Gabriele, Davidson Nancy E, Johannsson Oskar Th, Bedard Philippe L, Loi Sherene, Knox Susan, Cameron David A, Harbeck Nadia, Montoya Maite Lasa, Brandão Mariana, Vingiani Andrea, Caballero Carmela, Hilbers Florentine S, Yates Lucy R, Benelli Matteo, Venet David, Piccart Martine |
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences. Breast cancer research : BCR 2021 1 23 (1): 1. Priedigkeit Nolan, Ding Kai, Horne William, Kolls Jay K, Du Tian, Lucas Peter C, Blohmer Jens-Uwe, Denkert Carsten, Machleidt Anna, Ingold-Heppner Barbara, Oesterreich Steffi, Lee Adrian |
Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers. Annals of surgical oncology 2022 2 29 (6): 3578-3590. Huang Chi-Cheng, Tsai Yi-Fang, Liu Chun-Yu, Lien Pei-Ju, Lin Yen-Shu, Chao Ta-Chung, Feng Chin-Jung, Chen Yen-Jen, Lai Jiun-I, Phan Nam Nhut, Hsu Chih-Yi, Chiu Jen-Hwey, Tseng Ling-Mi |
Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer. Journal of Cancer 2022 2 13 (3): 869-876. Park Song Ee, Kim Hee Sung, Jung Eun-Jung, Suh Ja Hee, Min Hyeyoung, Chi Kyong-Choun, Kim Jong Won, Park Joong-Min, Hwang In G |
Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 2 28 (11): 2339-2348. Waks Adrienne G, Kim Dewey, Jain Esha, Snow Craig, Kirkner Gregory J, Rosenberg Shoshana M, Oh Coyin, Poorvu Philip D, Ruddy Kathryn J, Tamimi Rulla M, Peppercorn Jeffrey, Schapira Lidia, Borges Virginia F, Come Steven E, Brachtel Elena F, Warner Ellen, Collins Laura C, Partridge Ann H, Wagle Nikh |
The mutation and low expression of ARID1A are predictive of a poor prognosis and high immune infiltration in triple-negative breast cancer. Current cancer drug targets 2023 5 . Yuejing Wang, Zhuo Chen, Jing Wu, Hong Yan, Yiran Wang, Jie |
Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy. Journal of Cancer 2023 5 14 (7): 1216-1222. Jeong Eun Kim, Song Ee Park, Hee Jun Kim, In Gyu Hwa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: